Skip to content
stocks-llm

VOR BIOPHARMA INC (VOR) — insider trading

Health Care · NASDAQ

VOR BIOPHARMA INC (VOR) has 31 reported SEC Form 4 insider transactions in our data, including 16 open-market sales among the most recent 31 (latest 2026-10-02).

← VOR profile SEC Form 3/4/5 filings Ask about VOR's insider activity →

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-10-02 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. 10% owner Option exercise / conversion (derivative) 500 — $0 Form 4
2026-10-02 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. 10% owner Option exercise / conversion 500 $12.80 $6.4K Form 4
2026-08-24 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. 10% owner Option exercise / conversion (derivative) 1,500 — $0 Form 4
2026-08-24 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. 10% owner Option exercise / conversion 1,500 $3.74 $5.6K Form 4
2026-07-16 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. 10% owner Option exercise (in/at-the-money) (derivative) 2,100,000 $5.00 $10.50M Form 4
2026-07-16 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. 10% owner Open-market sale 213 $19.75 $4.2K Form 4
2026-07-16 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. 10% owner Option exercise (in/at-the-money) 2,100,000 $0.002 $4.2K Form 4
2026-07-07 ZACCARDELLI DAVID Director Grant / award / vesting (derivative) 42,658 — $0 Form 4
2026-06-11 Levin Andrew David Director Grant / award / vesting (derivative) 57,162 — $0 Form 4
2026-06-11 Beckman Daniella Director Grant / award / vesting (derivative) 53,283 — $0 Form 4
2026-06-11 Cumbo Alexander Director Grant / award / vesting (derivative) 56,345 — $0 Form 4
2026-06-11 Kalir Erez Director Grant / award / vesting (derivative) 57,162 — $0 Form 4
2026-06-11 Joustra Wouter Director Grant / award / vesting (derivative) 57,162 — $0 Form 4
2026-06-11 Namouni Fouad Director Grant / award / vesting (derivative) 56,549 — $0 Form 4
2026-06-11 Detheux Michel Director Grant / award / vesting (derivative) 57,162 — $0 Form 4
2026-06-11 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Grant / award / vesting (derivative) 57,162 — $0 Form 4
2026-04-22 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 165,150 $15.77 $2.60M Form 4
2026-04-20 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 171,963 $15.77 $2.71M Form 4
2026-04-17 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 458,411 $16.28 $7.46M Form 4
2026-04-15 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 53,644 $16.01 $858.8K Form 4
2026-04-14 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 153,735 $15.97 $2.46M Form 4
2026-04-13 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 530,610 $16.15 $8.57M Form 4
2026-04-10 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 828 $15.75 $13.0K Form 4
2026-04-09 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 135,201 $16.59 $2.24M Form 4
2026-04-08 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 130,862 $16.91 $2.21M Form 4
2026-04-08 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 353,242 $16.32 $5.76M Form 4
2026-04-06 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 6,775 $18.50 $125.3K Form 4
2026-04-06 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 44,728 $17.31 $774.2K Form 4
2026-04-06 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 537,754 $16.51 $8.88M Form 4
2026-04-02 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 1,525 $19.06 $29.1K Form 4
2026-04-02 RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. Director, 10% owner Open-market sale 258,475 $18.23 $4.71M Form 4

Ask the chat about VOR's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: VOR BIOPHARMA INC (VOR).

Last updated 2026-10-02 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.